Capsule development for oral solid dose (OSD) is often considered a relatively simple process. In practice, however, capsule-based drug products present a wide variety of complex formulation, manufacturing, and supply challenges. This complexity often does not arise from the capsule itself, but from the interactions between formulation properties, manufacturing requirements, material availability, packaging, and the clinical supply demands that must be managed throughout development.